首页> 美国卫生研究院文献>World Journal of Surgical Oncology >Persistent left superior vena cava: Review of the literature clinical implications and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients
【2h】

Persistent left superior vena cava: Review of the literature clinical implications and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients

机译:永久性左上腔静脉:与癌症患者中央静脉通路装置放置和静脉造影的一般原则有关的文献临床意义以及胸中央静脉解剖结构改变的相关性的综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Persistent left superior vena cava (PLSVC) represents the most common congenital venous anomaly of the thoracic systemic venous return, occurring in 0.3% to 0.5% of individuals in the general population, and in up to 12% of individuals with other documented congential heart abnormalities. In this regard, there is very little in the literature that specifically addresses the potential importance of the incidental finding of PLSVC to surgeons, interventional radiologists, and other physicians actively involved in central venous access device placement in cancer patients. In the current review, we have attempted to comprehensively evaluate the available literature regarding PLSVC. Additionally, we have discussed the clinical implications and relevance of such congenital aberrancies, as well as of treatment-induced or disease-induced alterations in the anatomy of the thoracic central venous system, as they pertain to the general principles of successful placement of central venous access devices in cancer patients. Specifically regarding PLSVC, it is critical to recognize its presence during attempted central venous access device placement and to fully characterize the pattern of cardiac venous return (i.e., to the right atrium or to the left atrium) in any patient suspected of PLSVC prior to initiation of use of their central venous access device.
机译:持续性左上腔静脉(PLSVC)代表胸腔全身静脉回流最常见的先天性静脉畸形,发生在普通人群中的比例为0.3%至0.5%,在其他有证据证明的持续性心脏异常的人群中,这一比例高达12% 。就这一点而言,很少有文献专门论述偶然发现PLSVC对积极参与癌症患者中心静脉通路装置放置的外科医生,介入放射科医生和其他医生的潜在重要性。在当前的审查中,我们试图全面评估有关PLSVC的可用文献。此外,我们已经讨论了这种先天畸形的临床意义和相关性,以及由于胸廓中心静脉系统解剖学引起的治疗性或疾病性改变,因为它们与成功放置中心静脉的一般原则有关癌症患者中的访问设备。特别是关于PLSVC,至关重要的是要在尝试进行中央静脉通路设备放置期间识别其存在,并充分表征开始前怀疑患有PLSVC的任何患者的心脏静脉回流模式(即右心房或左心房)中央静脉通路设备的使用情况。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号